Additionally, carcinoembryonic antigen (CEA) was assayed in our study, which is used for the clinical diagnosis of gastrointestinal cancer (Yang et al. 2018); besides, certain patients with a poor prognosis for HCC have a higher CEA level (Yoshikawa et al. 2017). This evidence concerns the gene CEACAM5 and hepatocellular carcinoma.